{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:46:28Z","timestamp":1791380788258,"version":"4.3.3"},"reference-count":53,"publisher":"MedWorks Media","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacol Bull"],"abstract":"<jats:p>Infertility, the inability to establish a clinical pregnancy after 12 months of regular unprotected sexual intercourse, is caused by a wide variety of both male and female factors. Infertility is estimated to affect between 8\u201312% of couples trying to conceive globally. Female factor infertility can be subdivided into the following broad categories: ovulatory dysfunction, fallopian tubal disease, uterine causes, and oocyte quality. Hyperprolactinemia causes ovulary dysfunction along with other hormonal abnormalities, such as decreased estrogen, which can lead to infertility. In this regard, antipsychotics are commonly used for both schizophrenia and bipolar disorder. The use of these medications can be associated with hyperprolactinemia and hyperprolactinemia associated infertility. Antipsychotic-induced hyperprolactinemia occurs through blockade of D 2 receptors on lactotroph cells of the anterior pituitary gland. Discontinuation of the hyperprolactinemia-inducing antipsychotic is an option, but this may worsen the patient\u2019s psychosis or mood. If antipsychotics are determined to be the culprit of infertility, the degree of hyperprolactinemia symptoms, length of treatment with the antipsychotic, and risk of relapse should be assessed prior to discontinuation, reduction, or switching of antipsychotic medications. The treatment of a women\u2019s mental health and her desire to have children should always be considered as treatment may influence fertility while on the medication.<\/jats:p>","DOI":"10.64719\/pb.4396","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:39:16Z","timestamp":1761046756000},"page":"131-148","source":"Crossref","is-referenced-by-count":9,"title":["Hyperprolactinemia, Clinical Considerations, and Infertility in Women on Antipsychotic Medications"],"prefix":"10.64719","volume":"51","author":[{"given":"Amber N","family":"Edinoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy S","family":"Silverblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley E","family":"Vervaeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassidy C","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eden","family":"Girma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica S","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa E","family":"Neuchat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Treniece N","family":"Eubanks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Viswanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Urits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54175","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R et al. The International Glossary on Infertility and Fertility Care, 2017. Fertil Steril. 2017;108:393\u2013406. Elsevier Inc.","DOI":"10.1016\/j.fertnstert.2017.06.005"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Inhorn MC, Patrizio P. Infertility around the globe: New thinking on gender, reproductive technologies and global movements in the 21st century. Hum Reprod Update. 2014;21:411\u2013426.","DOI":"10.1093\/humupd\/dmv016"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Hart RJ. Physiological aspects of female fertility: Role of the environment, modern lifestyle, and genetics. Physiol Rev. 2016;96:873\u2013909. American Physiological Society.","DOI":"10.1152\/physrev.00023.2015"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Kaiser UB. Hyperprolactinemia and infertility: New insights. J Clin Invest. 2012;122:3467\u20133468.","DOI":"10.1172\/JCI64455"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Bostwick JR, Pharm D, Guthrie SK, Pharm D, Ellingrod VL, Pharm D. Antipsychotic-Induced Hyperprolactinemia. Pharmacotherapy. 2009;29:64\u201373.","DOI":"10.1592\/phco.29.1.64"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Seeman M V. Women and psychosis. 2012:215\u201324. Women\u2019s Heal. p.","DOI":"10.2217\/WHE.11.97"},{"key":"ref7","unstructured":"Sit D. Women and bipolar disorder across the life span. J Am Med Womens Assoc. 2004:91\u2013100. p."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, Regional, and Global Trends in Infertility Prevalence Since 1990: A Systematic Analysis of 277 Health Surveys. PLoS Med. 2012;9","DOI":"10.1371\/journal.pmed.1001356"},{"key":"ref9","unstructured":"Infertility and impaired fecundity in the United States, 1982\u20132010: data from the National Survey of Family Growth\u2014PubMed"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod. 2003;18:199\u2013206. Oxford University Press.","DOI":"10.1093\/humrep\/deg005"},{"key":"ref11","unstructured":"Incidence of premature ovarian failure\u2014PubMed"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Franks S. Polycystic ovary syndrome in adolescents. Int J Obes (Lond) 2008:1035\u20131041. p.","DOI":"10.1038\/ijo.2008.61"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Dewailly D. Diagnostic criteria for PCOS: Is there a need for a rethink. Best Pract Res Clin Obstet Gynaecol. 2016:5\u201311. Bailliere Tindall Ltd. p.","DOI":"10.1016\/j.bpobgyn.2016.03.009"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Crosignani PG, Colombo M, Vegetti W, Somigliana E, Gessati A, Ragni G. Overweight and obese anovulatory patients with polycystic ovaries: Parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod. 2003;18:1928\u20131932. Oxford University Press.","DOI":"10.1093\/humrep\/deg367"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Tanbo T, Fedorcsak P. Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options. Acta Obstet Gynecol Scand. 2017:659\u2013667. Wiley-Blackwell. p.","DOI":"10.1111\/aogs.13082"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Prescott J, Farland L V, Tobias DK, Gaskins AJ, Spiegelman D, Chavarro JE et al. A prospective cohort study of endometriosis and subsequent risk of infertility. Hum Reprod. 2016;31:1475\u20131482. Oxford University Press.","DOI":"10.1093\/humrep\/dew085"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Macer ML, Taylor HS. Endometriosis and Infertility. Obstet Gynecol Clin North Am. 2012:535\u2013549. A Review of the Pathogenesis and Treatment of Endometriosis-associated Infertility. p.","DOI":"10.1016\/j.ogc.2012.10.002"},{"key":"ref18","unstructured":"Leiomyomas and infertility\u2014PubMed"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Jacoby VL, Fujimoto VY, Giudice LC, Kuppermann M, Washington AE. Racial and ethnic disparities in benign gynecologic conditions and associated surgeries. Am J Obstet Gynecol. 2010:514\u2013521. p.","DOI":"10.1016\/j.ajog.2010.02.039"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Smith PB, Phillips LE, Faro S, McGill L, Wait RB. Predominant sexually transmitted diseases among different age and ethnic group of indigent sexually active adolescents attending a family planning clinic. J Adolesc Heal Care. 1988;9:291\u2013295. Elsevier.","DOI":"10.1016\/0197-0070(88)90252-5"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Mitchell C, Prabhu M. Pelvic inflammatory disease: Current concepts in pathogenesis, diagnosis and treatment. Infect Dis Clin North Am. 2013:793\u2013809. Infect Dis Clin North Am. p.","DOI":"10.1016\/j.idc.2013.08.004"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Majumdar A, Mangal NS. Hyperprolactinemia. J Hum Reprod Sci. 2013:168\u2013175. Wolters Kluwer\u2014Medknow Publications. p.","DOI":"10.4103\/0974-1208.121400"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia: Mechanisms, clinical features and management. Drugs. 2004:2291\u2013314. Springer. p.","DOI":"10.2165\/00003495-200464200-00003"},{"key":"ref24","unstructured":"Schultz SH, North SW, Shields CG. Schizophrenia: A Review. 2007 Jun Am Fam Physician."},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016:86\u201397. Lancet Publishing Group. p.","DOI":"10.1016\/S0140-6736(15)01121-6"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Messias EL, Chen CY, Eaton WW. Epidemiology of Schizophrenia: Review of Findings and Myths. Psychiatr Clin North Am. 2007:323\u2013338. p.","DOI":"10.1016\/j.psc.2007.04.007"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Mura G, Petretto DR, Bhat KM, Carta MG. Schizophrenia: from Epidemiology to Rehabilitation. Clin Pract Epidemiol Ment Heal. 2012;8:52\u201366. Bentham Science Publishers Ltd.","DOI":"10.2174\/1745017901208010052"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Gaebel W, Zielasek J. Schizophrenia in 2020: Trends in diagnosis and therapy. Psychiatry Clin Neurosci. 2015;69:661\u2013673.","DOI":"10.1111\/pcn.12322"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Young AS, Fristad MA. Bipolar Disorder. Encycl Ment Heal Second Ed. 2016:178\u201382. Elsevier Inc. p.","DOI":"10.1016\/B978-0-12-397045-9.00002-1"},{"key":"ref30","unstructured":"Hirschfeld RMA. Am J Manag Care. 2007;13:164\u2013169. Screening for bipolar disorder."},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Rowland TA, Marwaha S. Epidemiology and risk factors for bipolar disorder. Ther Adv Psychopharmacol. 2018;8:251\u2013269. SAGE Publications.","DOI":"10.1177\/2045125318769235"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Hirschfeld RM. Differential diagnosis of bipolar disorder and major depressive disorder. J Affect Disord. 2014:S12\u2013S16. Elsevier B.V. p.","DOI":"10.1016\/S0165-0327(14)70004-7"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Ayano G. Bipolar Disorder: A Concise Overview of Etiology, Epidemiology Diagnosis and Management: Review of Literatures. SOJ Psychol. 2016:1\u20138. Symbiosis Group.","DOI":"10.15226\/2374-6874\/3\/2\/00131"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Meltzer HY. Update on typical and atypical antipsychotic drugs. Annu Rev Med. 2013:393\u2013406. p.","DOI":"10.1146\/annurev-med-050911-161504"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Miyamoto S, Miyake N, Jarskog LF, Fleischhacker WW, Lieberman JA. Pharmacological treatment of schizophrenia: A critical review of the pharmacology and clinical effects of current and future therapeutic agents. Mol Psychiatry. 2012:1206\u20131227. Nature Publishing Group. p.","DOI":"10.1038\/mp.2012.47"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Mortimer AM. How do we choose between atypical antipsychotics? Int J Neuropsychopharmacol. 2004 The advantages of amisulpride.","DOI":"10.1017\/S1461145704004134"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Lieberman JA, Scott Stroup T, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209\u20131223.","DOI":"10.1056\/NEJMoa051688"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Sykes DA, Moore H, Stott L, Holliday N, Javitch JA, Robert Lane J et al. Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors. Nat Commun. 2017;8","DOI":"10.1038\/s41467-017-00716-z"},{"key":"ref39","unstructured":"Casey DE. The relationship of pharmacology to side effects. J Clin Psychiatry. 1997;58:55\u201362. Physicians Postgraduate Press, Inc."},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Aringhieri S, Carli M, Kolachalam S, Verdesca V, Cini E, Rossi M et al. Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences. Pharmacol Ther. 2018:20\u201341. Elsevier Inc. p.","DOI":"10.1016\/j.pharmthera.2018.06.012"},{"key":"ref41","unstructured":"Arana GW. An overview of side effects caused by typical antipsychotics. J Clin Psychiatry. 2000:5\u201313. Physicians Postgraduate Press, Inc. p."},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: A critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry. 2005:79\u2013104. Nature Publishing Group. p.","DOI":"10.1038\/sj.mp.4001556"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Kane J, Honigfeld G, Singer Jack, Meltzer H. Clozapine for the Treatment-Resistant Schizophrenic A Double-blind Comparison With Chlorpromazine. Arch Gen Psychiatry. 1988:789\u2013796.","DOI":"10.1001\/archpsyc.1988.01800330013001"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Cohen LS, Viguera AC, Mcinerney KA, Freeman MP, Sosinsky AZ, Moustafa D et al. Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Am J Psychiatry. 2016;173:263\u2013270.","DOI":"10.1176\/appi.ajp.2015.15040506"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Huybrechts KF, Hern\u00e1ndez-D\u00edaz S, Patorno E, Desai RJ, Mogun H, Dejene SZ et al. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry. 2016;73:938\u2013946.","DOI":"10.1001\/jamapsychiatry.2016.1520"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Clark CT, Wisner KL. Treatment of Peripartum Bipolar Disorder. Obstet Gynecol Clin North Am. 2018:403\u2013417. W.B. Saunders. p.","DOI":"10.1016\/j.ogc.2018.05.002"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Smith S. Effects of antipsychotics on sexual and endocrine function in women: Implications for clinical practice. J Clin Psychopharmacol. 2003;23:27\u201332.","DOI":"10.1097\/01.jcp.0000084035.22282.31"},{"key":"ref48","unstructured":"Hacker N, Gambone J, Hobel C. 6th ed. Philadelphia: Elsevier; 2016. Hacker & Moore\u2019s Essentials of Obstetrics & Gynecology."},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Shibli-Rahhal A, Schlechte J. Hyperprolactinemia and infertility. Endocrinol Metab Clin North Am. 2011;40:837\u2013846. Elsevier Inc.","DOI":"10.1016\/j.ecl.2011.08.008"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Halbreich UM, Kahn LS. Hyperprolactinemia and Schizophrenia: REGULATION. J Psychiatr Pract. 2003;9:344\u2013353.","DOI":"10.1097\/00131746-200309000-00003"},{"key":"ref51","unstructured":"Arcari G, Mendes A, Sothern R. A Risperidone-Induced Prolactinoma Resolved when a Woman with Schizoaffective Disorder Switched to Ziprasidone: A Case Report. Innov Clin Neurosci. 2012"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA et al. Diagnosis and treatment of hyperprolactinemia: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011:273\u2013288. p.","DOI":"10.1210\/jc.2010-1692"},{"key":"ref53","unstructured":"Joffe H. Reproductive Biology and Psychotropic Treatments in Premenopausal Women With Bipolar Disorder. J Clin Psychiatry. 2007 Aug Physicians Postgraduate Press, Inc."}],"container-title":["Psychopharmacology Bulletin"],"original-title":[],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:28:44Z","timestamp":1791314924000},"score":1,"resource":{"primary":{"URL":"https:\/\/medworksmedia.com\/pb-article\/hyperprolactinemia-clinical-considerations-and-infertility-in-women-on-antipsychotic-medications\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":53,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.64719\/pb.4396","relation":{},"ISSN":["2472-2448"],"issn-type":[{"value":"2472-2448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}